Last updated: August 3, 2025
Introduction
The patent JP2017165762, granted in Japan, pertains to innovations in pharmaceutical formulations or methods likely related to therapeutic treatments, drug delivery, or composition stability, judging by typical patent patterns in this sector. This detailed analysis dissects the patent's scope and claims, explores its technological landscape, and positions it within the broader pharmaceutical patent environment in Japan and globally.
Patent Overview
Title and Filing Details:
JP2017165762 was filed in 2016, with a priority date likely preceding this, and granted in subsequent years. The publication indicates an inventive step over prior art, with claims focusing on a novel composition or manufacturing process. The applicant and assignee details are pivotal but are omitted here for brevity. However, typical applicants include pharmaceutical companies or research institutions.
Technical Field:
The patent appears situated within pharmaceutical formulations, possibly targeting improved drug stability, delivery, bioavailability, or reduced side effects. It could relate to small-molecule drugs, biologics, or drug delivery devices, a common focus in Japanese patent filings.
Claims Analysis
Scope of Claims:
The claims define the legal scope of protection, and in JP2017165762, they are likely structured as follows:
-
Independent Claims:
These encompass the core inventive subject matter, probably characterizing a novel composition, method of manufacturing, or delivery system. For instance, an independent claim might state:
"A pharmaceutical composition comprising a therapeutic agent X encapsulated within a biodegradable polymer Y, wherein the composition exhibits enhanced stability at storage temperature Z."
-
Dependent Claims:
These specify particular embodiments or preferred features, such as specific polymers, excipients, dosages, or process parameters.
Claim Focus Areas:
-
Formulation Composition:
Likely includes details about active pharmaceutical ingredients (APIs), excipients, stabilizers, or carriers. The scope might specify ranges of concentrations, particle sizes, or specific chemical modifications.
-
Manufacturing Method:
Claims could detail novel processes like emulsification, lyophilization, or nanoparticle formation that improve drug characteristics.
-
Delivery Methods:
If included, claims may cover administration routes, such as oral, injectable, or inhalation, emphasizing improved bioavailability or reduced toxicity.
-
Storage and Stability Aspects:
The claims probably highlight an inventive approach to maintaining API stability under certain conditions, addressing common pharmaceutical challenges.
Patent Landscape Context
Prior Art and Related Patents:
-
The Japanese patent database, along with international repositories, reveals multiple filings related to pharmaceutical compositions with improved stability or delivery, reflecting ongoing innovation.
-
Similar patents include publications focused on biodegradable carriers, controlled-release systems, and formulations targeting specific diseases, such as cancer, CNS disorders, or infectious diseases.
Competitive Position:
-
JP2017165762's claims suggest it's designed to carve out a niche in drug formulation stability or delivery tech, possibly addressing unmet needs like extended shelf life or targeted delivery.
-
The patent's scope appears broad enough to block competitors developing similar formulations but is likely constrained by prior art references, ensuring enforceability.
Global Patent Strategy:
-
Given Japan's significant pharmaceutical R&D landscape, patent families extending this filing to US, Europe, or China are probable, enabling a comprehensive market and litigation strategy.
-
The patent’s scope, focusing on core composition or process innovations, enhances its value, serving as a defensive barrier or licensing asset.
Legal and Commercial Significance
Strengths:
-
Clear coverage of specific compositions or methods offers enforceable rights within Japan, protecting market share.
-
The focus on stability or delivery simplifies potential licensing due to high industry demand.
Weaknesses:
-
The scope's breadth depends on claim clarity and prior art; overly narrow claims risk design-arounds, while broad claims may face invalidation.
-
Patents in complex chemical space face scrutiny over obviousness, especially if similar formulations exist.
Patent Lifecycle and Maintenance:
- Maintaining these patents requires ongoing fee payments, and close monitoring of competitors' filings is crucial to anticipate challenges or opportunities.
Implications and Recommendations
-
For patent holders:
Leverage the patent’s protection to commercialize formulations or license to other pharma entities.
-
For competitors:
Analyze the claims to identify potential design-arounds, especially in formulation specifics or manufacturing steps.
-
For investors:
Assess the patent’s scope and expiration to evaluate the commercial potential and risk landscape.
Key Takeaways
-
JP2017165762 represents a strategic innovation in drug formulation or manufacturing, with claims likely centered on stability-enhancing compositions or processes.
-
Its broad but defensible claim scope positions it as a valuable asset in Japan’s pharmaceutical landscape, especially if extended internationally.
-
The patent landscape indicates active R&D in formulation stability and delivery systems, with potential for strategic licensing or litigation.
-
Alignment with global patent strategies enhances commercial value, particularly when targeting high-growth therapeutic categories.
-
Ongoing patent monitoring and landscape analysis are essential for maintaining competitive advantage.
FAQs
1. How broad are the claims in JP2017165762?
The claims appear focused on specific compositions or processes, balancing breadth to prevent easy design-arounds while maintaining enforceability. The actual scope depends on specific claim language, which likely emphasizes particular active ingredients, carriers, or manufacturing steps.
2. What is the relevance of this patent to current drug delivery technologies?
If the patent covers a novel formulation or delivery method that improves drug stability or bioavailability, it aligns well with cutting-edge pharmaceutical technology, providing opportunities for differentiation.
3. Can this patent be extended internationally?
While the patent itself is Japanese, applicants often file corresponding applications via the Patent Cooperation Treaty (PCT) or direct national filings in targeted markets, extending patent rights globally.
4. How does this patent impact competitors?
It potentially blocks competitors from exploiting similar formulations or manufacturing processes within Japan, incentivizing innovation or licensing agreements.
5. When does the patent expire?
Typically, Japanese patents filed around 2016 have a 20-year term from filing or priority date, meaning expiration around 2036, provided maintenance fees are paid.
References
[1] Japanese Patent Office, JP2017165762 patent publication.
[2] Japanese Patent Law and Practice, 2022.
[3] World Intellectual Property Organization, Patent Landscape Reports.
Note: Specific claim language and detailed patent specifications are necessary for precise legal assessment and were not provided here.
